The provincial Health Technology Assessment Committee (HTAC) is preparing its annual call for topics to inform its 2022/2023 work plan.
The HTA process was established by health authority CEOs and the Deputy Minister in 2011 through a Memorandum of Understanding. The process provides evidence-informed advice about which devices, diagnostics, medical procedures or programs should receive funding in the province.
Some examples of recently assessed topics include; deep brain stimulation for Parkinson's disease, endovascular therapy for acute ischemic stroke and transcutaneous bilirubinometers for newborn hyperbilirubinemia.
The provincial HTA process assesses:
- Health technologies not publicly funded for possible funding (new assessments), and
- Health technologies already diffused within the system for optimal use (reassessments).
HTAC recommendations pass through two Standing Committees before reaching the Leadership Council, comprised of the health authority CEOs and Deputy Minister, for decision. Since its inception, over 95% of HTAC's recommendations have been approved.
Submit your nominations by Nov 30th, 2021!
If you are aware of any:
a) Health technologies that are not publicly funded that would significantly contribute to improved patient outcomes and provide value for money, or
b) Health technologies that are currently funded within the system but whose benefits may no longer be clear, please complete the single-page HTA Topic Nomination Form and send it via email to the Health Technology Assessment Office (HTA.Office@gov.bc.ca) before the end of November in order to be considered for the current fiscal year.
For assistance in completing the nomination form, contact rachael.ritchie@vch.ca. For further information on the provincial HTA process and HTAC, please visit http://www.health.gov.bc.ca/hta/
